Patent details

EP1879585 Title: USE OF PYRIMIDYLAMIMOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS

Basic Information

Publication number:
EP1879585
PCT Application Number:
PCT/US/2006/016541
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067519561
PCT Publication Number:
WO/2006/119154
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF PYRIMIDYLAMIMOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS
French Title of Invention:
UTILISATION DE DERIVES DE PYRIMIDYLAMINOBENZAMIDE POUR TRAITER LA MASTOCYTOSE SYSTEMIQUE
German Title of Invention:
VERWENDUNG VON PYRIMIDYLAMIMOBENZAMID-DERIVATEN ZUR BEHANDLUNG VON SYSTEMISCHER MASTOZYTOSE
SPC Number:

Dates

Filing date:
01/05/2006
Grant date:
17/04/2013
EP Publication Date:
17/04/2013
PCT Publication Date:
09/11/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/01/2008
EP B1 Publication Date:
17/04/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/05/2013
Expiration date:
01/05/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/05/2006
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
FABBRO Doriano
Address:
Switzerland (CH)

2

Name:
ALLAND Leila
Address:
United States (US)

3

Name:
MANLEY Paul, W.
Address:
Switzerland (CH)

4

Name:
MESTAN Jürgen
Address:
Germany (DE)

Priority

Priority Number:
676740 P
Priority Date:
02/05/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/506;
Filing date Document type Number of pages